Key Findings:  Perillyl alcohol demonstrates sufficient neuroprotective activity to provide new avenues in therapy of Parkinson's Disease and its apparent target being restoration of MMP can lead to better understanding of the disease.
Type of Study:  Laboratory Study
Study Result:  Positive
Cannabinoids Studied:  Not Applicable
Phytocannabinoid Source:  Not Applicable